
According to data from Benzinga Pro, during Q1, Insmed's (NASDAQ:INSM) reported sales totaled $53.11 million. Despite a 16.25% increase in earnings, the company posted a loss of $94.62 million. Insmed collected $56.12 million in revenue during Q4, but reported earnings showed a $112.98 million loss.